Skip to main content

SauveBio

Biosafety in Flow Cytometry

Biosafety in Flow Cytometry: Protecting Personnel, Samples, and Data Quality

Flow cytometry allows researchers to rapidly analyze individual cells and particles based on their physical and fluorescent characteristics. It is widely used for immune profiling, cell counting, biomarker analysis, cell-cycle studies, vaccine research, cancer research, and many other applications.

However, flow cytometry workflows may involve human blood, primary tissues, live cell cultures, genetically modified cells, infectious agents, or other potentially hazardous biological materials. Because these samples pass through instrument fluidics and because cell sorting can generate aerosols, biosafety must be considered at every stage of the workflow.

Strong biosafety practices do more than protect laboratory personnel. They also help prevent contamination, preserve sample quality, reduce instrument downtime, and support reliable flow cytometry data.

What This Blog Covers

  • Biological hazards associated with flow cytometry
  • Biosafety levels and risk assessments
  • Safe sample preparation and handling
  • Aerosol risks during cell sorting
  • Personal protective equipment
  • Fixation and sample inactivation
  • Instrument cleaning and waste disposal
  • Spill and exposure response
  • How biosafety supports accurate flow cytometry results

What Is Biosafety in Flow Cytometry?

Biosafety refers to the practices, equipment, facility controls, and training used to reduce exposure to hazardous biological materials.

In flow cytometry, biosafety begins before a sample is placed on the instrument. Researchers must evaluate where the sample came from, whether it contains viable organisms or cells, how it was treated, and which procedures will be performed.

The Centers for Disease Control and Prevention’s Biosafety in Microbiological and Biomedical Laboratories, commonly known as the BMBL, emphasizes that biological containment should be based on a procedure-specific risk assessment rather than the identity of the sample alone.

For example, an established cell line and a fresh human blood sample may both be analyzed on the same flow cytometer, but they may require different containment practices, cleaning procedures, and personal protective equipment.

Common Biological Hazards in Flow Cytometry

Potential hazards can vary considerably depending on the sample and experimental design. Common examples include:

  • Human blood and blood-derived products
  • Bone marrow samples
  • Primary tissues and dissociated cells
  • Patient-derived samples
  • Established and primary cell lines
  • Viral vectors
  • Genetically modified cells
  • Bacteria, viruses, and other infectious agents
  • Samples containing hazardous drugs or chemicals

Human-derived materials are commonly handled using universal or standard precautions because their complete infectious status may not be known.

The condition of the sample also matters. Live, unfixed cells generally require more careful handling than samples that have undergone a validated inactivation procedure. However, a sample should not automatically be considered safe simply because a fixative was added.

Understanding Biosafety Levels

Laboratories are commonly categorized into four biosafety levels: BSL-1 through BSL-4. Each level represents a combination of laboratory practices, safety equipment, facility design, and containment requirements.

  • BSL-1

BSL-1 practices are generally appropriate for well-characterized biological agents that are not known to consistently cause disease in healthy adults.

  • BSL-2

BSL-2 practices are commonly used when working with human-derived materials, primary cells, blood products, viral vectors, and moderate-risk biological agents. Many research flow cytometry laboratories operate under BSL-2 practices.

  • BSL-3 and BSL-4

BSL-3 and BSL-4 laboratories are designed for higher-risk agents and require increasingly strict containment, facility, training, and operational controls.

The appropriate biosafety level should be determined through an institutional risk assessment. The assigned level may also change depending on the procedure. A sample that can be safely handled during routine analysis may require additional controls when it is processed through a droplet-based cell sorter because of the potential for aerosol generation.

Complete a Risk Assessment Before Starting

A flow cytometry risk assessment should consider both the sample and the procedure.

Important questions include:

  • What is the source of the sample?
  • Is the sample human- or animal-derived?
  • Could it contain an infectious agent?
  • Are the cells alive, fixed, or otherwise inactivated?
  • Has the inactivation method been validated?
  • Will the sample be analyzed or sorted?
  • Could the procedure create aerosols, splashes, or leaks?
  • What pressure and nozzle size will be used?
  • What personal protective equipment is required?
  • How will the instrument and workspace be decontaminated?
  • How will liquid and solid waste be handled?
  • What will happen if there is a spill, clog, leak, or exposure?

Risk assessments should be performed with the laboratory’s biosafety officer, institutional biosafety committee, flow cytometry core manager, or other designated safety personnel when appropriate.

Safe Sample Preparation and Handling

Biosafety controls should begin during sample collection and preparation and not only when the tube reaches the cytometer.

Samples should be clearly labeled and transported in secure, leak-resistant containers. Centrifugation should be performed using appropriate sealed rotors or safety cups when there is a risk of aerosol generation.

Researchers should avoid practices that create unnecessary splashes or droplets, including forcefully ejecting liquids from pipette tips. Mouth pipetting should never be performed.

The sample concentration and volume should also be appropriate for the instrument. Samples containing excessive debris, clumps, or aggregates can contribute to fluidic instability and nozzle clogs. Proper filtering, gentle resuspension, and validated sample-preparation methods can help reduce these problems.

Aerosol Risks During Cell Sorting

Cell sorting presents additional biosafety concerns compared with routine analytical flow cytometry.

Many cell sorters use pressure to pass a liquid stream through a small nozzle. The stream is then separated into droplets, allowing selected cells to be directed into collection vessels. Under normal operation, this process is carefully controlled. However, a partial nozzle obstruction or unstable stream can generate aerosols containing sample material.

For this reason, cell sorting is considered a procedure-related aerosol hazard. ISAC cell-sorter biosafety standards recommend risk-based containment measures, instrument-specific operating procedures, appropriate PPE, and validation of aerosol containment.

Aerosol-management systems create negative pressure around the sort chamber and direct air through high-efficiency filtration. NIH guidance requires its cell sorters to use an aerosol-management or evacuation system during sorting at BSL-2 and higher containment levels.

Containment systems must also be tested. Recent ISAC-associated work emphasizes verifying aerosol containment before hazardous samples are processed, particularly under simulated failure conditions such as a disrupted stream or partial nozzle obstruction.

Personal Protective Equipment

Appropriate PPE depends on the risk assessment and the procedures being performed. Common laboratory PPE may include:

  • A properly fastened laboratory coat or disposable gown
  • Disposable gloves
  • Safety glasses or goggles
  • Face protection when splashes are possible
  • Additional respiratory or protective equipment when required by the risk assessment

Gloves should be changed when contaminated, damaged, or after handling potentially hazardous samples. They should also be removed before touching phones, keyboards, door handles, notebooks, or other clean surfaces.

PPE should not replace good technique, engineering controls, or proper instrument containment. It is one part of a broader biosafety system.

Fixation and Sample Inactivation

Fixation can preserve cellular features, stabilize certain targets, and reduce biological activity. Common fixation methods use substances such as formaldehyde or paraformaldehyde.

However, fixation should not automatically be assumed to completely inactivate every biological hazard. The effectiveness of fixation depends on several factors, including:

  • The biological agent
  • Fixative concentration
  • Exposure time
  • Sample volume
  • Cell concentration
  • Temperature
  • Mixing and penetration
  • The presence of proteins or other biological material

When inactivation is being used as a biosafety control, the method should be scientifically supported and accepted by the institution’s biosafety personnel.

Researchers must also consider how fixation affects the experiment. Fixatives can alter fluorescent proteins, antibody epitopes, cell morphology, scatter characteristics, and staining intensity. Biosafety controls should therefore be incorporated into assay development and validation rather than added after the panel has already been designed.

Cleaning and Decontaminating the Cytometer

Flow cytometers contain tubing, flow cells, probes, waste containers, and other internal surfaces that may contact the sample. These components must be cleaned according to the instrument manufacturer’s instructions and the laboratory’s approved procedures.

A decontamination plan should address:

  • The sample-injection area
  • Fluidic tubing
  • Flow cells and nozzles
  • Sort chambers
  • Collection areas
  • Waste lines and waste containers
  • Instrument surfaces
  • Benches and nearby work areas

Only compatible disinfectants should be used. Some chemicals can damage fluidics, seals, metals, optical components, or instrument surfaces. Laboratories should follow validated procedures rather than assuming that a stronger disinfectant or longer exposure is always better.

Cleaning schedules should include routine cleaning, end-of-day procedures, decontamination after hazardous samples, and additional cleaning after spills, leaks, or clogs.

Flow Cytometry Waste Disposal

Flow cytometry produces both liquid and solid biological waste.

Liquid waste may contain sheath fluid, cells, staining reagents, cleaning agents, and potentially infectious biological material. Waste containers should be securely closed, appropriately labeled, and managed according to institutional requirements.

Solid waste may include:

  • Sample tubes
  • Pipette tips
  • Gloves
  • Plates
  • Filters
  • Collection tubes
  • Absorbent materials
  • Contaminated disposable PPE

Sharps must be placed in approved sharps containers. Biological waste should not be placed in regular trash unless it has been handled according to the laboratory’s approved disposal procedures.

Because disinfectants and laboratory chemicals may have specific disposal restrictions, biological and chemical waste requirements must both be considered.

Responding to Spills and Exposures

Every flow cytometry laboratory should have a written plan for spills and occupational exposures.

During a spill, personnel should stop work, restrict access to the affected area, and follow the laboratory’s spill-response procedure. The response may depend on the material, spill size, location, and possibility of aerosol generation.

Potential exposures may include:

  • Splashes to the eyes, nose, or mouth
  • Contact with broken skin
  • Needlestick or sharps injuries
  • Leaking sample tubes
  • Aerosol exposure
  • Contact with contaminated instrument components

Exposed areas should be washed or flushed promptly according to institutional procedures, and the incident should be reported immediately. Medical evaluation should not be delayed while waiting to determine whether the sample was infectious.

The incident should also be documented and reviewed so the laboratory can identify why it occurred and whether procedures, training, or equipment need to be changed.

How Biosafety Supports Data Quality

Biosafety and data quality are closely connected.

Poor sample handling can cause contamination, cell death, aggregation, altered marker expression, and changes in light-scatter characteristics. These problems can interfere with gating, reduce staining consistency, increase background fluorescence, and produce results that do not accurately represent the original sample.

Inadequate instrument cleaning may contribute to carryover between samples, fluidic instability, clogs, and unexpected events in flow cytometry data.

Clear biosafety procedures help standardize how samples are collected, transported, prepared, analyzed, and discarded. This consistency makes it easier to compare results between operators, instruments, experiments, and study time points.

Flow Cytometry Biosafety Checklist

Before beginning a flow cytometry experiment, confirm that:

  • The biological hazards have been identified.
  • A procedure-specific risk assessment has been completed.
  • The sample is approved for the instrument and laboratory.
  • Required PPE is available and being worn correctly.
  • Sample tubes are properly labeled and securely closed.
  • Centrifugation and sample preparation controls are appropriate.
  • The sample is free from avoidable clumps and debris.
  • Fixation or inactivation claims have been validated.
  • The instrument’s containment systems are functioning.
  • Aerosol containment has been tested when required.
  • Cleaning and decontamination procedures are available.
  • Liquid and solid waste containers are ready.
  • Spill and exposure procedures are understood.
  • Operators have completed the required training.

Final Thoughts

Biosafety in flow cytometry is not a single cleaning step or piece of protective equipment. It is a complete process that begins with sample evaluation and continues through preparation, instrument operation, decontamination, waste disposal, and incident response.

The safest workflow is one built around a documented risk assessment, appropriate containment, trained personnel, validated procedures, and clear communication between researchers, flow cytometry operators, and institutional biosafety staff.

By integrating biosafety into assay planning from the beginning, laboratories can better protect their personnel while also improving sample consistency, instrument reliability, and confidence in flow cytometry results.